PLCD1 is a functional tumor suppressor inducing G2/M arrest and frequently methylated in breast cancer

Chromosome 3p harbors multiple tumor-suppressor genes. PLCD1, located at 3p22, encodes an enzyme that mediates regulatory signaling of energy metabolism, calcium homeostasis and intracellular movement. We investigated the epigenetic alterations of PLCD1 and its tumor suppressor function in breast cancer. Frequent downregulation/silencing of PLCD1 was shown in most breast cancer cell lines by using semi-quantitative PCR. Promoter methylation of PLCD1 was detected in 78% (7/9) of cell lines and 52% (13/25) of primary tumors by Methylation-specific PCR (MSP), but not in any tumor adjacent breast tissues and normal breast tissues, which was further confirmed by bisulfite genomic sequencing (BGS). The silencing of PLCD1 could be reversed by pharmacological demethylation, indicating a methylation-mediated mechanism. Ectopic expression of PLCD1 in silenced breast cancer cells significantly inhibited their colony formation. In addition, PLCD1 inhibited tumor cell migration and induced cell cycle G2/M arrest. Thus, this study for the first time demonstrates the frequent inactivation of PLCD1 by promoter methylation and its tumor inhibitory function in breast cancer. Tumor-specific methylation of PLCD1 might serve as a biomarker for possible early detection and prognosis prediction of breast cancer.

[1]  Roger L. Williams,et al.  Crystal structure of a mammalian phosphoinositide-specific phospholipase Cδ , 1996, Nature.

[2]  Q. Tao,et al.  Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. , 1999, The American journal of pathology.

[3]  C Eng,et al.  Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. , 2001, Human molecular genetics.

[4]  J. Minna,et al.  Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers , 2002, Oncogene.

[5]  Ichiro Mori,et al.  Chromosome 3p and breast cancer , 2002, Journal of Human Genetics.

[6]  Q. Tao,et al.  Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. , 2002, Human molecular genetics.

[7]  M. Paz,et al.  Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. , 2003, Human molecular genetics.

[8]  Catherine Morrissey,et al.  Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers , 2003, Oncogene.

[9]  Qian Tao,et al.  The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma , 2004, Oncogene.

[10]  Paul Cairns,et al.  Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients , 2004, Clinical Cancer Research.

[11]  Qian Tao,et al.  The Stress-Responsive Gene GADD45G Is a Functional Tumor Suppressor, with Its Response to Environmental Stresses Frequently Disrupted Epigenetically in Multiple Tumors , 2005, Clinical Cancer Research.

[12]  Jonathan D. Stallings,et al.  Nuclear Translocation of Phospholipase C-δ1 Is Linked to the Cell Cycle and Nuclear Phosphatidylinositol 4,5-Bisphosphate* , 2005, Journal of Biological Chemistry.

[13]  R. S. Sidhu,et al.  Regulation of Phospholipase C-δ1 through Direct Interactions with the Small GTPase Ral and Calmodulin* , 2005, Journal of Biological Chemistry.

[14]  P. Devreotes,et al.  Phosphoinositide signaling plays a key role in cytokinesis , 2006, The Journal of cell biology.

[15]  Moon S. Chen,et al.  Cancer Incidence, Mortality, and Associated Risk Factors Among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese Ethnicities , 2007, CA: a cancer journal for clinicians.

[16]  Zhong-ying Shen,et al.  Epigenetic silencing of a Ca2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers , 2007, Proceedings of the National Academy of Sciences.

[17]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[18]  Dan Xie,et al.  Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma. , 2007, Cancer research.

[19]  G. Drin,et al.  Stimulation of phospholipase Cbeta by membrane interactions, interdomain movement, and G protein binding--how many ways can you activate an enzyme? , 2007, Cellular signalling.

[20]  Q. Tao,et al.  WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. , 2007, Blood.

[21]  L. Hesson,et al.  Evaluation of the 3p21.3 tumour-suppressor gene cluster , 2007, Oncogene.

[22]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[23]  P. Sham,et al.  Single‐nucleotide polymorphism‐mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma , 2008, International journal of cancer.

[24]  M. Salto‐Tellez,et al.  The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle. , 2008, Journal of hepatology.

[25]  T. Kataoka,et al.  Multiple roles of phosphoinositide-specific phospholipase C isozymes. , 2008, BMB reports.

[26]  Jun Yu,et al.  OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation , 2008, PloS one.

[27]  G. G. Kelley,et al.  Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity. , 2008, The Biochemical journal.

[28]  Wei Zheng,et al.  CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. , 2009, Cancer research.

[29]  Jonathan D. Stallings,et al.  Expression and function of phospholipase C in breast carcinoma. , 2009, Advances in enzyme regulation.

[30]  M. Thun,et al.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.

[31]  P. Corn.  Methylation marks the path for biomarker development in breast cancer research , 2009, Cancer biology & therapy.